Quarterly Result21 May 2026, 08:01 pm
iSERA Lifesciences Audited Results for FY26 Approved
AI Summary
iSERA Lifesciences Limited (formerly Covidh Technologies Limited) has announced the approval of its audited financial results (standalone) for the quarter and year ended March 31, 2026. The decision was made during a Board of Directors meeting held on May 21, 2026, which commenced at 07:00 P.M. and concluded at 07:40 P.M. The board also approved the Independent Auditor’s Report and a declaration for unmodified opinion regarding the audited standalone financial results.
Key Highlights
- Audited Financial Results (Standalone) for FY26 approved.
- Independent Auditor’s Report on FY26 results approved.
- Declaration for unmodified opinion issued for FY26 results.
- Board meeting held on May 21, 2026, via video conference.
Price Impact
More from COVIDH